Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second-quarter ...

Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the ...

Cellebrite (CLBT) boasts strong growth potential with robust financials, digital forensics leadership, and a durable moat.

Despite strong figures, Cellebrite DI Ltd. (NASDAQ:CLBT) lowered its outlook on key metrics for the full-year period, with revenues now pegged at $465 million to $475 million, versus the $470 ...

Cellebrite DI Ltd. (CLBT) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.

We came across a bullish thesis on Cellebrite DI Ltd. on topsecretstocks’s Substack. In this article, we will summarize the bulls’ thesis on CLBT. Cellebrite DI Ltd.’s share was trading at $13.98 as ...

In recent trading, shares of Cellebrite DI Ltd (Symbol: CLBT) have crossed above the average analyst 12-month target price of $10.00, changing hands for $10.74/share. When a stock reaches the ...

Both FUTU and CLBT are impressive stocks with solid earnings outlooks, but based on these valuation figures, we feel that FUTU is the superior value option right now. Buy 5 Stocks BEFORE Election Day ...

In its updated report, Cellebrite DI Ltd. (NASDAQ:CLBT) climbed to a net income of $19.48 million from a $23.8 million net loss in the same period last year.